Curated News
By: NewsRamp Editorial Staff
November 05, 2026
SS Innovations Hits 195 Telesurgeries, Expands Robotic System Base
TLDR
- SS Innovations' SSi Mantra system has enabled 195 telesurgeries, with a 45% installed base increase to 244 systems across 12 countries, strengthening its market position.
- The SSi Mantra robotic system enables remote telesurgery by integrating surgical robotics with communications technology, supporting procedures like cardiac surgery across distances.
- SS Innovations aims to make robotic surgery affordable and accessible globally, improving healthcare access and outcomes for more patients through telesurgery.
- SS Innovations has trained about 1,500 physicians on its SSi Mantra platform, which has facilitated 14,503 cumulative surgical procedures, including cardiac telesurgeries.
Impact - Why it Matters
The progress in telerobotic surgery demonstrated by SS Innovations signals a transformative shift in healthcare delivery, particularly for patients in remote or underserved areas who lack access to specialized surgical expertise. By enabling cardiac and other complex procedures to be performed remotely, the technology can reduce travel burdens, shorten waiting times, and improve outcomes. Moreover, the company's affordable robotic systems and international expansion efforts, including regulatory clearances in the U.S. and EU, could intensify competition in the surgical robotics market, potentially lowering costs and accelerating adoption worldwide. This matters because it brings advanced surgical care closer to millions of patients, while also offering investors exposure to a rapidly growing segment of medical technology.
Summary
SS Innovations International (NASDAQ: SSII) is making significant strides in the telerobotic surgery market, leveraging advancements in surgical robotics and communications technology to enable remote medical procedures. The company's SSi Mantra surgical robotic system has facilitated 195 robotic telesurgeries as of September 28, 2026, including complex cardiac operations performed across substantial distances. This milestone underscores the potential of telesurgery to extend specialized care to underserved regions.
Alongside its telesurgery achievements, SS Innovations reported a 45% increase in its installed base, reaching 244 systems across 12 countries. Cumulative surgical procedures have climbed to 14,503, with approximately 1,500 physicians trained on the platform. The company has also expanded internationally, launching new robotic cardiac surgery programs in Colombia, Sri Lanka, and India. To further penetrate global markets, SS Innovations is actively pursuing U.S. FDA clearance and European Union CE marking, which would open doors to additional regions.
SS Innovations develops the SSi Mantra surgical robotic system and the SSi Mudra suite of surgical instruments, aiming to make robotic surgery affordable and accessible worldwide. Headquartered in India but operating as a U.S. company, it focuses on cost-effective, user-friendly solutions. For more information, visit SSInnovations.com or LinkedIn. The latest updates are available in the company's newsroom at https://ibn.fm/SSII. This news was distributed by TechMediaWire, a specialized communications platform within the Dynamic Brand Portfolio @ IBN.
Source Statement
This curated news summary relied on content distributed by InvestorBrandNetwork (IBN). Read the original source here, SS Innovations Hits 195 Telesurgeries, Expands Robotic System Base
